These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16979316)

  • 41. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients.
    Zavagno G; Carcoforo P; Franchini Z; Renier M; Barutta L; De Salvo GL; Maravegias K; Capitanio G; Nitti D; Lise M
    Eur J Surg Oncol; 2005 Sep; 31(7):715-20. PubMed ID: 16005176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.
    Takei H; Kurosumi M; Yoshida T; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Asakawa H; Oba H; Inoue K; Tabei T
    Breast; 2009 Aug; 18(4):244-7. PubMed ID: 19559610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
    Noguchi M
    Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term.
    Sanli I; Lemaire BM; Muller AJ; van Kleffens HJ; Van Poll-Franse LV; van Dijk M
    Breast J; 2009; 15(3):236-41. PubMed ID: 19645777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma.
    Bleiweiss IJ; Nagi CS; Jaffer S
    J Clin Oncol; 2006 May; 24(13):2013-8. PubMed ID: 16606970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer.
    Motomura K; Komoike Y; Inaji H; Hasegawa Y; Kasugai T; Noguchi S; Koyama H
    Br J Surg; 2002 Aug; 89(8):1032-4. PubMed ID: 12153631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era.
    Gray RJ; Mulheron B; Pockaj BA; Degnim A; Smith SL
    Am J Surg; 2007 Dec; 194(6):845-8; discussion 848-9. PubMed ID: 18005782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
    Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
    Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
    Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy.
    Imoto S; Isaka H; Sakemura N; Ito H; Imi K; Miyamoto K
    Breast Cancer; 2012 Apr; 19(2):104-9. PubMed ID: 22038672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
    Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
    Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Axillary lymph node recurrence after sentinel lymph node biopsy for breast cancer].
    Mathelin C; Salvador S; Guyonnet JL
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):253-9. PubMed ID: 17317037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.